News FDA Approves Beovu to Treat Diabetic Macular Edema June 1, 2022 Read More » Brand Medications with Generic Alternatives Anticipated to be Approved in June May 31, 2022 Read More » Evrysdi Now Indicated to Treat SMA in Patients of Any Age May 31, 2022 Read More » Kymriah Granted New Indication for Follicular Lymphoma May 28, 2022 Read More » Opdivo Gains New Indications to Treat Esophageal Cancer May 27, 2022 Read More » Fifth Neulasta Biosimilar Approved May 27, 2022 Read More » Tibsovo Now Indicated for Newly Diagnosed Acute Myeloid Leukemia May 25, 2022 Read More » Tyvaso DPI Approved to Treat High Blood Pressure in the Lungs May 24, 2022 Read More » FDA Approves Novel Treatment for Plaque Psoriasis May 24, 2022 Read More » Page1 … Page26 Page27 Page28 Page29 Page30 … Page38 Benefit Advisors & Employees - Want to know more? Members: Please call the number on the back of your ID card or e-mail member.services@benecardpbf.com Clients: Contact your Client Relations Manager Full Name(Required)Email(Required) Comment(Required)Company Name(Required)CAPTCHA
Brand Medications with Generic Alternatives Anticipated to be Approved in June May 31, 2022 Read More »